Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.280
+0.090 (7.56%)
At close: May 14, 2025, 4:00 PM
1.290
+0.010 (0.77%)
After-hours: May 14, 2025, 7:58 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $132.43 million as of May 14, 2025. Its market cap has increased by 301.83% in one year.
Market Cap
132.43M
Enterprise Value
137.28M
1-Year Change
301.83%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $132.43M, a decrease of -74.24%. That is a compound annual growth rate of -31.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 123.12M | 171.22% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 643.16B |
| Johnson & Johnson | 352.13B |
| AbbVie | 316.01B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 282.46B |
| Abbott Laboratories | 223.66B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |